High‐risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020
Authors:
Open Access
- 9 November 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (6) , 962-968
Abstract
As human papillomavirus (HPV) immunisation and HPV‐based cervical cancer (CC) screening programmes expand across sub‐Saharan Africa, we investigated the potential impact of human immunodeficiency virus (HIV) status on high‐risk (HR)‐HPV distribution among women with CC in Côte d'Ivoire. From July 2018 to June 2020, paraffin‐embedded CC specimens diagnosed in Abidjan, Côte d'Ivoire were systematically collected and tested for HR‐HPV DNA. Type‐specific HR‐HPV prevalence was compared according to HIV status. Of the 170 CC specimens analysed (median age 52 years, interquartile range: [43.0‐60.0]), 43 (25.3%) were from women living with HIV (WLHIV) with a median CD4 count of 526 [373‐833] cells/mm3 and 86% were on antiretroviral therapy (ART). The overall HR‐HPV prevalence was 89.4% [95% CI: 84.7‐94.1]. All were single HR‐HPV infections with no differences according to HIV status (P = .8). Among HR‐HPV‐positive CC specimens, the most prevalent HR‐HPV types were HPV16 (57.2%), HPV18 (19.7%), HPV45 (8.6%) and HPV35 (4.6%), with no significant differences according to HIV status. Altogether, infection with HPV16/18 accounted for 71.1% [95% CI: 55.9‐86.2] of CC cases in WLHIV vs 78.9% [95% CI: 71.3‐86.5] in women without HIV (P = .3). The study confirms the major role of HPV16/18 in CC in Côte d'Ivoire and should support a regional scale‐up of HPV16/18 vaccination programmes regardless of HIV status. However, vaccines targeting additional HR‐HPV types, including HPV45 and HPV35, could further decrease future CC incidence in Côte d'Ivoire, both for WLHIV and women without HIV.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism
This publication has 19 references indexed in Scilit:
- Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2016
- Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected womenAmerican Journal of Obstetrics and Gynecology, 2016
- Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub‐Saharan AfricaInternational Journal of Cancer, 2013
- Cross-roads in the classification of papillomavirusesVirology, 2013
- Human papillomavirus distribution in invasive cervical carcinoma in sub‐Saharan Africa: could HIV explain the differences?Tropical Medicine & International Health, 2012
- Human papillomavirus types in glandular lesions of the cervix: A meta‐analysis of published studiesInternational Journal of Cancer, 2012
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publicationInternational Journal of Cancer, 2010
- Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive WomenJNCI: Journal of the National Cancer Institute, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI: Journal of the National Cancer Institute, 1995